Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Purchases of Investments
Cash used to buy marketable securities and other investments.
Purchases of Investments history
Currency unavailable · from the cash flow
No Purchases of Investments data reported for this period type.
Purchases of Investments vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
ORKAOruka Therapeutics, Inc. | LTM Sep 2026 | $1.01B USD | +564.4% | — | — |
| LTM Sep 2026 | $1.01B USD | +143.8% | +136.5% | 1114.4% | |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | $652.69M USD | +217.4% | +0.0% | 8822.5% |
| LTM Mar 2026 | $81.41M USD | -37.4% | -37.8% | 972.9% | |
| LTM Jun 2026 | $77.55M USD | +111.7% | +36.5% | 27.5% | |
| LTM Mar 2026 | $73.86M USD | -83.4% | -37.4% | 31.8% | |
| LTM Mar 2026 | $0 USD | — | — | — | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | — | — | — | — | — |
| Peer median (excluding ODTX) | — | +127.8% | +0.0% | 972.9% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.